Gantrisin

Active Ingredient(s): Sulfisoxazole
FDA Approved: * December 4, 1953
Pharm Company: * ROCHE
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Gantrisin Overview

Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an dimethyl-isoxazole substituent. It possesses antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment. See also Sulfamethoxazole Sulfapyridine External links Sulfisoxazole at the US National Library of Medicine Medica...

Read more Gantrisin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sulfafurazole

Recent Gantrisin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sulfisoxazole
  • Emulsion: 1gm/5ml
  • Injection: 400mg/ml
  • Ointment: 4%
  • Solution/drops: 4%
  • Suspension: 500mg/5ml
  • Syrup: 500mg/5ml
  • Tablet: 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sulfisoxazole or a similar ingredient: (4 results)